Our human skin homogenate is prepared from ethically sourced, non-diseased human skin tissue and processed under controlled conditions to preserve the native enzymatic and protein profile. This homogenate provides a physiologically relevant in vitro matrix for studying cutaneous metabolism, topical drug absorption, skin barrier function, and dermal toxicity.
Containing both epidermal and dermal components, the homogenate supports early-stage screening and mechanistic studies in dermatology, cosmetic development, and transdermal drug delivery. Each batch is quality-controlled to ensure reproducibility and biochemical integrity.